Literature DB >> 26003923

The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Kristoffer R Brandvold1, Richard I Morimoto2.   

Abstract

Protein homeostasis (proteostasis) is inextricably tied to cellular health and organismal lifespan. Aging, exposure to physiological and environmental stress, and expression of mutant and metastable proteins can cause an imbalance in the protein-folding landscape, which results in the formation of non-native protein aggregates that challenge the capacity of the proteostasis network (PN), increasing the risk for diseases associated with misfolding, aggregation, and aberrant regulation of cell stress responses. Molecular chaperones have central roles in each of the arms of the PN (protein synthesis, folding, disaggregation, and degradation), leading to the proposal that modulation of chaperone function could have therapeutic benefits for the large and growing family of diseases of protein conformation including neurodegeneration, metabolic diseases, and cancer. In this review, we will discuss the current strategies used to tune the PN through targeting molecular chaperones and assess the potential of the chemical biology of proteostasis.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  aggregation; heat shock protein; pharmacology; protein folding; small molecule modulators

Mesh:

Substances:

Year:  2015        PMID: 26003923      PMCID: PMC4569545          DOI: 10.1016/j.jmb.2015.05.010

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  200 in total

1.  Novel inhibitors of heat shock protein Hsp70-mediated luciferase refolding that bind to DnaJ.

Authors:  Joel A Cassel; Sergey Ilyin; Mark E McDonnell; Allen B Reitz
Journal:  Bioorg Med Chem       Date:  2012-04-11       Impact factor: 3.641

Review 2.  Fine-tuning multiprotein complexes using small molecules.

Authors:  Andrea D Thompson; Amanda Dugan; Jason E Gestwicki; Anna K Mapp
Journal:  ACS Chem Biol       Date:  2012-07-23       Impact factor: 5.100

Review 3.  Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers.

Authors:  Komal Jhaveri; Tony Taldone; Shanu Modi; Gabriela Chiosis
Journal:  Biochim Biophys Acta       Date:  2011-10-29

Review 4.  Development and application of Hsp90 inhibitors.

Authors:  David B Solit; Gabriela Chiosis
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

5.  Heat shock protein 90: inhibitors in clinical trials.

Authors:  Marco A Biamonte; Ryan Van de Water; Joseph W Arndt; Robert H Scannevin; Daniel Perret; Wen-Cherng Lee
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

6.  Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.

Authors:  Karen L Soldano; Arif Jivan; Christopher V Nicchitta; Daniel T Gewirth
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

Review 7.  Herbal modulation of P-glycoprotein.

Authors:  Shufeng Zhou; Lee Yong Lim; Balram Chowbay
Journal:  Drug Metab Rev       Date:  2004-02       Impact factor: 4.518

8.  MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation.

Authors:  K Koya; Y Li; H Wang; T Ukai; N Tatsuta; M Kawakami; L B Chen
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

Review 9.  Discovery and development of heat shock protein 90 inhibitors.

Authors:  Tony Taldone; Weilin Sun; Gabriela Chiosis
Journal:  Bioorg Med Chem       Date:  2008-11-06       Impact factor: 3.641

10.  Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase.

Authors:  Gabriela Chiosis; Brian Lucas; Alexander Shtil; Henri Huezo; Neal Rosen
Journal:  Bioorg Med Chem       Date:  2002-11       Impact factor: 3.641

View more
  50 in total

1.  Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome.

Authors:  Brighid M O'Donnell; Timothy D Mackie; Arohan R Subramanya; Jeffrey L Brodsky
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

Review 2.  A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond.

Authors:  Tony Taldone; Tai Wang; Anna Rodina; Naga Vara Kishore Pillarsetty; Chander S Digwal; Sahil Sharma; Pengrong Yan; Suhasini Joshi; Piyusha P Pagare; Alexander Bolaender; Gail J Roboz; Monica L Guzman; Gabriela Chiosis
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

Review 3.  Adapting to stress - chaperome networks in cancer.

Authors:  Suhasini Joshi; Tai Wang; Thaís L S Araujo; Sahil Sharma; Jeffrey L Brodsky; Gabriela Chiosis
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

4.  The folding competence of HIV-1 Tat mediated by interaction with TAR RNA.

Authors:  Jung Min Kim; Hee Sun Choi; Baik Lin Seong
Journal:  RNA Biol       Date:  2017-04-18       Impact factor: 4.652

Review 5.  Inhibitors and chemical probes for molecular chaperone networks.

Authors:  Jason E Gestwicki; Hao Shao
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 6.  Small molecules as therapeutic agents for inborn errors of metabolism.

Authors:  Leslie Matalonga; Laura Gort; Antonia Ribes
Journal:  J Inherit Metab Dis       Date:  2016-12-13       Impact factor: 4.982

7.  Toxicant-mediated redox control of proteostasis in neurodegeneration.

Authors:  Stefanos Aivazidis; Colin C Anderson; James R Roede
Journal:  Curr Opin Toxicol       Date:  2018-12-28

8.  Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97.

Authors:  Celeste Alverez; Michelle R Arkin; Stacie L Bulfer; Raffaele Colombo; Marina Kovaliov; Matthew G LaPorte; Chaemin Lim; Mary Liang; William J Moore; R Jeffrey Neitz; Yongzhao Yan; Zhizhou Yue; Donna M Huryn; Peter Wipf
Journal:  ACS Med Chem Lett       Date:  2015-10-23       Impact factor: 4.345

Review 9.  Translational Control by Prion-like Proteins.

Authors:  Liying Li; J P McGinnis; Kausik Si
Journal:  Trends Cell Biol       Date:  2018-03-09       Impact factor: 20.808

Review 10.  HSF1: Guardian of Proteostasis in Cancer.

Authors:  Chengkai Dai; Stephen Byers Sampson
Journal:  Trends Cell Biol       Date:  2015-11-18       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.